Scopolamine Market, By Dosage Form (Tablet, Syrup, Injection, Patch, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

PUBLISHED: February 14, 2025

PAGES: 151 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Global Scopolamine Market is estimated to be valued at USD 516.2 Mn in 2025 and is expected to reach USD 797.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 516.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.40%	2032 Value Projection:	USD 797.4 Mn

Figure. Scopolamine Market Share (%), By Region 2025

Scopolamine is a pharmaceutical compound that is commonly used to curb motion sickness and nausea. Global scopolamine market has witnessed steady growth over the past few due to factors such as increasing recreational drug usage and rising application across numerous end-use industries. Scopolamine is predominantly extracted from plants belonging to the Solanaceae family of which Datura stramonium or Jimson weed is the major commercial source. It acts as a competitive antagonist of muscarinic acetylcholine receptors in the brainstem and other parts of the central nervous system to block signals from the vestibular system affecting balance and motion perception. The drug is available in various dosage forms including tablets, patches, and injections to effectively manage symptoms of motion sickness, post-operative nausea & vomiting, and nausea associated with cancer chemotherapy.

Market Dynamics:

Rising sea and air travel, increasing consumption of antiemetic drugs, and growing clinical use of scopolamine patches for postoperative care can drive the global scopolamine market growth. However, adverse effects associated with overdosage and restrictions on plant-derived alkaloids extraction can hamper the market growth. Ongoing R&D to develop new galenic formulations, focus on combination therapies, and evaluation of additional therapeutic applications can offer opportunities for market players. Fluctuating prices of raw materials also impact the supply and pricing strategies adopted by different market participants.

Key Features of the Study:

This report provides in-depth analysis of the global scopolamine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global scopolamine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer, Baxter, Caleb Pharmaceuticals, Alkaloids of Australia.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine market.

Detailed Segmentation-

By Dosage Form:
- Tablet
- Syrup
- Injection
- Patch
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Alchem International
- Integra LifeSciences Holding Corporation
- Alkaloids Corporation
- Boehringer Ingelheim
- Caleb Pharmaceuticals, Inc.
- Centroflora Group
- Fine Chemicals Corporation
- GlaxoSmithKline plc
- Henan Fusen Pharmaceutical Co., Ltd.
- Laboratorio RAAM de Sahuayo
- Mylan N.V. (part of Viatris)
- Novartis AG
- Pfizer Inc.
- Pharmaceutical Associates, Inc.
- Phytex Australia
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Global Alkaloids

Product Code: CMI1965

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Scopolamine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Scopolamine Market, By Dosage Form, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Tablet
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Syrup
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Patch
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Scopolamine Market, By Distribution Channel, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Scopolamine Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Alchem International
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Integra LifeSciences Holding Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Alkaloids Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Caleb Pharmaceuticals, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Centroflora Group
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fine Chemicals Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Henan Fusen Pharmaceutical Co., Ltd.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Laboratorio RAAM de Sahuayo
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mylan N.V. (part of Viatris)
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pharmaceutical Associates, Inc.
- Phytex Australia
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Global Alkaloids